ArticleJournal of experimental & clinical cancer research : CR2026
ERK/GATAD2A/SAA1 axis drives osimertinib resistance via NF-κB and macrophage reprogramming in EGFR-mutated lung adenocarcinoma.
Junkan Zhu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.